Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Single-cell ATAC-Seq of recurrent pediatric high-grade glioma

ABSTRACT: We performed scATAC-seq on glioblastoma tissue samples taken at time of recurrence to map the global chromatin profiles of glioblastoma cells and associated non-neoplastic cells

ORGANISM(S): Homo sapiens

PROVIDER: GSE163656 | GEO | 2021/10/20

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Single-cell ATAC-Seq of pediatric high-grade glioma

Project description:We performed scATAC-seq on glioblastoma tissue samples taken at time of initial surgical resection to map the global chromatin profiles of glioblastoma cells and associated non-neoplastic cells

2021-10-20 | GSE163655 | GEO

Single-cell ATAC-Seq of Adult GBM surgical specimens

Project description:We performed scATAC-seq on primary glioblastoma tissue samples taken at time of initial resection to map the global chromatin profiles of glioblastoma cells and associated non-neoplastic cells

2021-01-27 | GSE139136 | GEO

Single-cell ATAC-Seq of recurrent pediatric high-grade glioma

Project description:Single-cell ATAC-Seq of recurrent pediatric high-grade glioma

| PRJNA687016 | ENA

Management of pediatric low-grade glioma.

Project description: Not available

| S-EPMC6664811 | biostudies-literature

Epigenomic Landscape and 3D Genome Structure in Pediatric High-Grade Glioma

Project description:Pediatric high-grade gliomas (pHGGs), including glioblastoma multiforme (GBM) and diffuse intrinsic pontine glioma (DIPG), are highly morbid childhood brain tumors. Even with treatment, overall survival is poor, making pHGG the number one cause of cancer death in children. Up to 80% of DIPGs harbor a somatic missense mutation in genes encoding Histone H3 proteins. To investigate whether this H3K27M mutation is associated with distinct chromatin structure that alters transcription regulation, we generated the first high-resolution Hi-C maps of pHGG cell lines and tumor tissue. By integrating transcriptome (RNA-Seq), enhancer landscape (ChIP-Seq), genome structure (Hi-C), and chromatin accessibility (ATAC-Seq) datasets from H3K27M mutant and wild-type specimens, we identified tumor specific enhancers and regulatory networks for known oncogenes. In addition, we identified distinct genomic structural variations that lead to enhancer hijacking and gene co-amplification, including A2M, JAG2, FLRT1.

2021-06-03 | GSE162976 | GEO

EGFR pathway expression persists in recurrent glioblastoma independent of amplification status

Project description:Background: Glioblastoma mortality is driven by tumour progression or recurrence despite administering a therapeutic arsenal consisting of surgical resection, radiation, and alkylating chemotherapy. The genetic changes underlying tumour progression and chemotherapy resistance are poorly understood. Methods: In this work, we sought to define the relationship between EGFR amplification status, EGFR mRNA expression, and EGFR pathway activity. We compared RNA-sequencing data from matched primary and recurrent tumour samples (N = 40 patients, 20 with EGFR amplification). Results: In the setting of glioblastoma recurrence, the EGFR pathway was overexpressed regardless of EGFR amplification status, suggesting a common genomic endpoint in recurrent glioblastoma, although EGFR amplification did associate with higher EGFR mRNA expression. Three of forty patients in the study cohort had EGFR-amplified tumours and received targeted EGFR therapy. Their molecular subtypes and clinical outcomes did not significantly differ from patients who received conventional chemotherapy. Conclusion: Our findings suggest that while the EGFR amplification may confer a unique molecular profile in primary glioblastoma, pathway analysis reveals upregulation of the EGFR pathway in recurrence, regardless of amplification status. As such, the EGFR pathway may be a key mediator of glioblastoma progression.

2023-01-25 | GSE222515 | GEO

Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis.

Project description: Not available

| S-EPMC5823744 | biostudies-literature

Pseudoprogression in pediatric low-grade glioma after irradiation.

Project description: Not available

| S-EPMC8717050 | biostudies-literature

Carbon Ion Beam Reirradiation in Recurrent High-Grade Glioma.

Project description: Not available

| S-EPMC6995286 | biostudies-literature

Single-cell ATAC-Seq of pediatric high-grade glioma

Project description:Single-cell ATAC-Seq of pediatric high-grade glioma